The importance of thrombin inhibitors in the antithrombotic pharmacotherapy

Journal Title: Postępy Nauk Medycznych - Year 2010, Vol 23, Issue 10

Abstract

Activation of blood coagulation is a physiological process which consists of a series of zymogens that can be converted by limited proteolysis to active enzymes leading to the generation of thrombin. Trombin is a multifunctional plasma serine protease which has a central role in controlling hemostasis. Trombin is responsible for conversion fibrinogen into fibrin, platelet activation and feedback activation of other coagulation factors. Consequently, control of thrombin generation regulates plasma coagulant activity. For this reason the thrombin inhibition is a key for successful novel antithrombotic pharmacotherapy. Thrombin inhibitors are classified as indirect inhibitors (heparin) and direct inhibitors. Currently for clinical use are available 3 parenteral direct thrombin inhibitors: hirudin and bivalirudin which bind both the catalytic site and exosite I of thrombin, and argatroban which binds only to the active site. The next novel class currently available for clinical use are orally bioavailable direct thrombin inhibitors: ximelagatran and dabigatran which reversible bind only to the active site of thrombin molecule. Clinical studies carried in last years show that the most promising drug is dabigatran, which may be an alternative to vitamin K antagonists. This article describes the thrombin generation mechanisms in vivo as well as mechanism of action and pharmacokinetic of indirect and direct thrombin inhibitors currently available in clinical use.

Authors and Affiliations

Michał Bijak, Mateusz Bobrowski

Keywords

Related Articles

Can Interferon-Gamma Release Assays be helpful for the diagnosis of pulmonary and extrapulmonary tuberculosis?

The diagnosis of pulmonary tuberculosis and tuberculous pleurisy standard methods is difficult and slow. Now, high hopes to cells of T cells secreting interferon-gamma in response to antigens of Mycobacterium tuberculosi...

Rodzinna polipowatość gruczolakowata jelita grubego

Rodzinna polipowatość jelita (FAP) jest dobrze poznanym zespołem predyspozycji do występowania choroby nowotworowej, dziedzicznym w sposób autosomalno dominujący ze skłonnością do występowania dużej liczby polipów w okrę...

Preoperative embolisation in spine/vertebrae tumors

Introduction. Neoplasmatic tumors within vertebrae column can be a cause of mielopathic changes. They also lead to increased risk of pathological fractions of influenced vertebrae. Both those reasons may proceed to serio...

DNA and RNA analyses in detection of genetic predisposition to cancer

During the past decade many new molecular methods for DNA and RNA analysis have emerged. The most popular in the past like SSCP, HET, CMC, DGGE, RFLP or ASA have been replaced by methods which allowed more cost effective...

Elevated troponin I level – a predictor of poor prognosis after ischemic stroke

Introduction. Multiple ECG abnormalities can be observed during the acute phase of ischemic stroke (IS). Right-hemisphere stroke with insular involvement is also a risk factor for cardiac complications. ECG monitoring an...

Download PDF file
  • EP ID EP53774
  • DOI -
  • Views 148
  • Downloads 0

How To Cite

Michał Bijak, Mateusz Bobrowski (2010). The importance of thrombin inhibitors in the antithrombotic pharmacotherapy. Postępy Nauk Medycznych, 23(10), -. https://europub.co.uk/articles/-A-53774